Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
112.00    1.50 (1.36%)
Bid:
111.50
Ask:
112.00
Spread: 0.50 (0.448%)
Market Cap: £110.38m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Director/PDMR Shareholding

26 Aug 2016 07:00

RNS Number : 1956I
Eurocell plc
26 August 2016
 

24 August 2016

 

Eurocell PLC

 

Director/PDMR Shareholding

 

Eurocell plc (LSE: ECEL) a market leading, vertically integrated UK manufacturer and distributor of innovative window, door and roofline PVS products, was notified on 24 August 2016 that Chairman Robert Lawson acquired 15,739 shares at 170.69p.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Robert Lawson

2.

Reason for the notification

a)

Position / status

Chairman

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell PLC

b)

Legal Entity Identifier

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each

 

ISIN number GB00BVV2KN49

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

170.69p

15,739

 

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

N/A - single transaction

e)

Date of the transaction

24 August 2016 (UK)

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

For further information:

 

Eurocell PLC

Tel: 01779 842 100

Mark Kelly, CEO

 

 

Teneo Strategy

Tel: 020 7240 2486

Ben Foster

Camilla Cunningham

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGURWRUPQPGA
Date   Source Headline
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
24th Aug 20163:41 pmRNSDirector/PDMR Shareholding
23rd Aug 20167:00 amRNSHalf Year Results
21st Jul 20163:12 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSAwards to Directors and PDMRs
19th May 20162:43 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Trading Update
21st Apr 20166:04 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSResult of Placing
19th Apr 20164:36 pmRNSProposed Placing
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.